Ultrasound Patch Could Form Future Pacemaker

2026-06-10 · Source: IEEE Spectrum · Field: Health & Wellbeing — Pharmaceuticals & Biotechnology, Clinical Care & Medical Practice, Medical Devices & Health Technology · Depth: Advanced, quick

Summary

California and Massachusetts scientists have developed a noninvasive pacemaker, detailed in Nature Biomedical Engineering, which aims to eliminate the need for surgical battery replacements required every five years for traditional devices. This innovative system combines a wearable ultrasound patch, roughly the size of an iPod Shuffle, with a gene therapy injection. The gene therapy introduces RNA into heart cells, prompting them to produce a sound-sensitive protein that enables them to "hear" high-frequency ultrasound waves. These waves, emitted by the chest-worn patch, stimulate the cells' ion channels, causing a calcium influx that cues the heart to beat. The approach has demonstrated effectiveness in rats, pig hearts, and human heart cell samples. While promising, clinical viability hinges on proving comparable reliability to existing pacemakers under various conditions and addressing gene therapy's cost, safety, and regulatory hurdles.

Key takeaway

For medical device developers and cardiologists evaluating future pacing solutions, this noninvasive ultrasound pacemaker represents a potential paradigm shift from traditional surgical implants. You should closely monitor its clinical development, especially regarding long-term reliability under various conditions, cost-effectiveness, and the regulatory pathways for its gene therapy component. This technology could significantly reduce surgical complications and improve patient quality of life, warranting careful consideration for future integration into cardiac care.

Key insights

A noninvasive pacemaker combines sonogenetics via RNA-based gene therapy with a wearable ultrasound patch to stimulate heartbeats.

Principles

• Sonogenetics enables cell modulation with sound.
• RNA therapy can introduce protein production.
• Noninvasive pacing avoids surgical risks.

Method

Patients receive a gene therapy injection to make heart cells produce a sound-sensitive protein, followed by wearing an ultrasound patch that emits high-frequency waves to stimulate heartbeats.

In practice

• Explore sonogenetics for other organ stimulation.
• Develop non-surgical alternatives for chronic conditions.

Topics

• Noninvasive Pacemakers
• Sonogenetics
• Gene Therapy
• Ultrasound Technology
• Cardiac Pacing
• Medical Device Development

Best for: AI Scientist, Research Scientist, Domain Expert, Tech Journalist

Related on AIssential

• China has approved the world’s first invasive brain-computer chip—here’s what’s next — China's NEO BCI, less invasive and government-backed, is the first globally approved for commercial use, offering hope for paralysis patients.
• Your phone can use tiny skin-colour changes to measure your heart rate — Smartphone cameras can measure heart rate by detecting subtle skin color changes.
• How AI Ultrasound Systems Are Improving Real-Time Diagnostic Accuracy in Clinical Settings — AI ultrasound systems enhance diagnostic accuracy and expand access by automating measurements, guiding image acquisition, and accelerating interpretation.
• Magnetic mixer improves 3D bioprinting — MagMix prevents cell sedimentation in 3D bioprinting, ensuring uniform cell distribution and consistent tissue quality.
• This tiny implant, smaller than a grain of salt, can read your brain — A new microscale optoelectronic neural implant wirelessly transmits brain activity using light, enabling long-term, less invasive monitoring.
• PULSE: Privileged Knowledge Transfer from Rich to Deployable Sensors for Embodied Multi-Sensory Learning — PULSE transfers privileged EDA knowledge to low-cost sensors, improving stress detection without requiring EDA at inference.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by IEEE Spectrum.